Evaluation and guide for embedding opioid use disorder education in health professions’ curricula

Author:

Salvador Julie G.,Bolaños-Sacoman Sindy L.,Katzman Joanna G.,Morrison Ann E.,Fox Lindsay E.,Schneider Jennifer S.,Bhatt Snehal R.,Kincaid Tyler W.,Waldorf V. Ann

Abstract

Abstract Background Morbidity and mortality from Opioid Use Disorder is a health crisis in the United States. During the COVID-19 pandemic, there was a devastating increase of 38.4% in overdose deaths from the 12-month period leading up to June 2019 compared with the 12-month period leading up to May 2020, primarily driven by synthetic opioids. Buprenorphine is an effective medication for opioid use disorder but uptake is slow due in part to lack of provider knowledge, confidence, and negative attitudes/stigma toward patients with OUD. Addressing these barriers in academic training is a promising approach to building workforce able to effectively treat opioid use disorder. Methods Our university developed a training for pre-licensure physicians, physician assistants and psychiatric nurse practitioners that included the DATA Waiver training and a shadowing experience. Expected outcomes included improved knowledge, skills and attitudes about persons with OUD and buprenorphine treatment, plans to provide this treatment post-graduation, for pre-licensure learners to have completed all requirements to prescribe buprenorphine post-graduation, and for the training to be embedded into school’s curricula. Results Results were positive overall including improved knowledge and attitudes toward persons with OUD, better understanding of the benefits of this treatment for patients, increased confidence and motivation to provide this treatment post-graduation. The training is now embedded in each program’s graduation requirements. Conclusion Developing a didactic and experiential training on buprenorphine treatment for opioid use disorder and embedding it into medical, physician assistant, and psychiatric nurse practitioner licensure programs can help prepare future providers to treat opioid use disorder in a range of settings. Key to replicating this program in other university settings is to engage faculty members who actively provide treatment to persons with OUD to ensure shadowing opportunities and serve as role models for learners.

Funder

Substance Abuse and Mental Health Services Administration

Publisher

Springer Science and Business Media LLC

Subject

Education,General Medicine

Reference18 articles.

1. CDC., 2021. Centers for Disease Control and Prevention, Injury Center, Drug Overdose. Drug Overdose Deaths Remain High. Available at https://www.cdc.gov/drugoverdose/deaths/index.html#:~. Accessed January 30,2023.

2. CDC, National Center for Health Statistics., 2021. Centers for Disease Control and Prevention,. Drug Overdose Deaths in the U.S. Top 100,000 Annually. Available at https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2021/20211117.htm Accessed April 8, 2022.

3. SAMHSA., 2017. Substance Abuse and Mental Health Services Administration. SAMSHA Reaffirms Efforts to Address the Public Health Emergency on the Opioid Crisis [Webpage]. https://www.samhsa.gov/newsroom/press-announcements/201710260100 Accessed September 7, 2021.

4. NIDA. 2021. Overview. National Institute on Drug Abuse [Webpage]. Available at https://www.drugabuse.gov/publications/research-reports/medications-to-treat-opioid-addiction/overview. Accessed September 9, 2021.

5. NIDA. 2016, November 1. Effective Treatments for Opioid Addiction. Available at [Webpage]https://www.drugabuse.gov/publications/effective-treatments-opioid-addiction. Accessed September 9, 2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3